Vogenx (VOGX)
Vogenx, Inc. operates as a clinical-stage drug development company that develops therapeutics for metabolic including post-bariatric hypoglycemia, or PBH, and g...
- Open
- 14.800
- High
- 16.225
- Low
- 14.800
- Prev. Close
- 14.780
- Volume
- 14.28K
- Turnover
- 222.10K
- Avg Price
- 15.554
- Bid/Ask Ratio
- -84.91%
- Amplitude
- 9.64%
- 52wk High
- 16.650
- Volume Ratio
- 0.00
- Turnover Ratio
- 0.16%
News
- Price Alert · 4 hours ago
Pre-market hot trades in US stocks: Vogenx up 15.02% in pre-market; Credo Tech up 3.12% in pre-market
- StockTitan · 8 hours ago
Jones Served as Sole Book-Running Manager for Vogenx's $81.3 Million Initial Public Offering | VOGX Stock News
- RenaissanceCapital · 1 day ago, 11:00 AM
US IPO Weekly Winners & Losers
- RenaissanceCapital · 2 days ago, 04:50 PM
US IPO Weekly Recap: Copper foils producer and metabolic disorders biotech list amid August lull
- StockTitan · Aug 13 at 07:35 AM
Vogenx Announces Closing of Initial Public Offering | VOGX Stock News
